Da: WorldofBooks, Goring-By-Sea, WS, Regno Unito
EUR 0,86
Quantità: 3 disponibili
Aggiungi al carrelloPaperback. Condizione: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
Da: 3Brothers Bookstore, Egg harbor township, NJ, U.S.A.
Condizione: very_good. Cover may have light wear, pages in very good condition and binding is sturdy; may have other light shelf wear or creases. May have notes or highlighting.
hardcover. Condizione: Fine. LIKE NEW!!! Has a red or black remainder mark on bottom/exterior edge of pages.
Condizione: good. Fast Free Shipping â" Good condition. It may show normal signs of use, such as light writing, highlighting, or library markings, but all pages are intact and the book is fully readable. A solid, complete copy that's ready to enjoy.
Da: Webster's Bookstore Cafe, Inc., State College, PA, U.S.A.
hardcover. Condizione: Very Good. A clean and tight copy.
Hardcover. Condizione: As New.
Condizione: very_good. This book is in Very Good condition. The cover and pages have minor shelf wear. Binding is tight and pages are intact.
hardcover. Condizione: Very Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
Da: Reuseabook, Gloucester, GLOS, Regno Unito
EUR 3,70
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Used; Good. Dispatched, from the UK, within 48 hours of ordering. This book is in good condition but will show signs of previous ownership. Please expect some creasing to the spine and/or minor damage to the cover.
Condizione: As New. Unread book in perfect condition.
Hardcover. Condizione: new. Hardcover. In Pharmanomics, investigative journalist Nick Dearden digs down into the way we produce our medicines and finds that Big Pharma is failing us, with catastrophic consequences.Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financialising medicine from Purdue's rapacious marketing of highly addictive OxyContin through Martin Shkreli's hiking the price of a lifesaving drug to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication.Since the 1990s, Big Pharma has gone out of its way to protect its property through the patent system. As a result, the business has focused not on researching new medicines but on building monopolies. This system has helped restructure our economy away from invention and production in order to benefit financial markets. It has fundamentally reshaped the relationship between richer and poorer countries, as the access to new medicines and the permission to manufacture them is ruthlessly policed. In response, Dearden offers a pathway to a fairer, safer system for all. How Big Pharma failed to end a pandemic, and what it tells us about the global economy Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Condizione: New.
Da: Brit Books, Milton Keynes, Regno Unito
EUR 4,16
Quantità: 3 disponibili
Aggiungi al carrelloPaperback. Condizione: Used; Very Good. ***Simply Brit*** Welcome to our online used book store, where affordability meets great quality. Dive into a world of captivating reads without breaking the bank. We take pride in offering a wide selection of used books, from classics to hidden gems, ensuring there is something for every literary palate. All orders are shipped within 24 hours and our lightning fast-delivery within 48 hours coupled with our prompt customer service ensures a smooth journey from ordering to delivery. Discover the joy of reading with us, your trusted source for affordable books that do not compromise on quality.
Hardback. Condizione: New. In Pharmanomics, investigative journalist Nick Dearden digs down into the way we produce our medicines and finds that Big Pharma is failing us, with catastrophic consequences.Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financialising medicine - from Purdue's rapacious marketing of highly addictive OxyContin, through Martin Shkreli's hiking the price of a lifesaving drug, to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication.Since the 1990s, Big Pharma has gone out of its way to protect its property through the patent system. As a result, the business has focused not on researching new medicines but on building monopolies. This system has helped restructure our economy away from invention and production in order to benefit financial markets. It has fundamentally reshaped the relationship between richer and poorer countries, as the access to new medicines and the permission to manufacture them is ruthlessly policed. In response, Dearden offers a pathway to a fairer, safer system for all.
EUR 24,20
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. In Pharmanomics, investigative journalist Nick Dearden digs down into the way we produce our medicines and finds that Big Pharma is failing us, with catastrophic consequences.Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financialising medicine - from Purdue's rapacious marketing of highly addictive OxyContin, through Martin Shkreli's hiking the price of a lifesaving drug, to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication.Since the 1990s, Big Pharma has gone out of its way to protect its property through the patent system. As a result, the business has focused not on researching new medicines but on building monopolies. This system has helped restructure our economy away from invention and production in order to benefit financial markets. It has fundamentally reshaped the relationship between richer and poorer countries, as the access to new medicines and the permission to manufacture them is ruthlessly policed. In response, Dearden offers a pathway to a fairer, safer system for all.
Da: WorldofBooks, Goring-By-Sea, WS, Regno Unito
EUR 17,92
Quantità: 5 disponibili
Aggiungi al carrelloPaperback. Condizione: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
EUR 22,21
Quantità: 1 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Condizione: NEW.
Condizione: New.
EUR 24,97
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
EUR 23,09
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 315 pages. 9.50x6.25x1.25 inches. In Stock.
EUR 18,86
Quantità: 1 disponibili
Aggiungi al carrellohardcover. Condizione: New.
EUR 19,14
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. New copy - Usually dispatched within 4 working days.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 25,95
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. 2023. Hardback. . . . . .
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 24,08
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 20,22
Quantità: 10 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 21,46
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New. 2023. Hardback. . . . . . Books ship from the US and Ireland.
Editore: Penguin Random House
ISBN 10: 1804291455 ISBN 13: 9781804291450
Da: INDOO, Avenel, NJ, U.S.A.
EUR 20,79
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread copy in mint condition.